Luteal phase after conventional stimulation in the same ovarian cycle might improve the management of poor responder patients fulfilling the Bologna criteria: a case series

Objective: To assess the clinical contribution of luteal-phase stimulation (LPS) to follicular-phase stimulation (FPS) in a single ovarian cycle (DuoStim) for poor responder patients fulfilling the Bologna criteria. Design: Observational study (years 2015-2017) including women satisfying >= 2 of the following characteristics: maternal age >= 40 years and/or <= 3 oocytes retrieved after previous conventional stimulation and/or reduced ovarian reserve (i.e., antral follicle count <7 follicles or antimullerian hormone <1.1 ng/mL). The LPS was started regardless of the outcome of the FPS. Setting: Private in vitro fertilization center. Patient(s): A total of 100 of 297 patients fulfilling the Bologna criteria chose to undergo DuoStim. Intervention(s): The FPS and LPS with the same antagonist protocol and agonist trigger, intracytoplasmic sperm injection with ejaculated sperm, preimplantation genetic testing for aneuploidies, and vitrified-warmed euploid single blastocyst transfer. Main Outcome Measure(s): The contribution of LPS to the cumulative live birth rate (CLBR) per intention-to-treat (ITT). Result(s): Patients (100) underwent FPS (maternal age, 42.1 +/- 1.4 y; previous in vitro fertilization cycles with %3 collected oocytes, 0.7 +/- 0.9; antral follicle count, 3.8 +/- 1.2 follicles; and antimullerian hormone, 0.56 +/- 0.3 ng/mL). Ninety-one patients completed DuoStim. All patients were included in the analysis. More oocytes were obtained after LPS with similar developmental and chromosomal competence as paired FPS-derived ones. The CLBR per ITT increased from 7% after FPS to 15% after DuoStim. Conversely, the CLBR per ITT among the 197 patients that chose a conventional controlled ovarian stimulation strategy was 8%, as only 17 patients who were not pregnant returned for a second stimulation after the first attempt (drop-out rate, 81%). Conclusion(s): The LPS-derived oocytes increased the CLBR per ITT in a single ovarian cycle in patients fulfilling the Bologna criteria. The DuoStim strategy is promising to manage this thorny population of patients, especially to avoid discontinuation after a first failed attempt. ((C) 2019 by American Society for Reproductive Medicin e.)